209 related articles for article (PubMed ID: 8039883)
1. Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection.
Johansen HK; Espersen F; Cryz SJ; Hougen HP; Fomsgaard A; Rygaard J; Høiby N
Infect Immun; 1994 Aug; 62(8):3146-55. PubMed ID: 8039883
[TBL] [Abstract][Full Text] [Related]
2. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats.
Johansen HK; Hougen HP; Cryz SJ; Rygaard J; Høiby N
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1337-46. PubMed ID: 7551392
[TBL] [Abstract][Full Text] [Related]
3. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
4. Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A.
Johansen HK; Cryz SJ; Høiby N
APMIS; 1994 Jul; 102(7):545-53. PubMed ID: 7917224
[TBL] [Abstract][Full Text] [Related]
5. Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: experimental studies in animals.
Johansen HK
APMIS Suppl; 1996; 63():5-42. PubMed ID: 8944052
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection.
Ciofu O; Bagge N; Høiby N
APMIS; 2002 Dec; 110(12):881-91. PubMed ID: 12645667
[TBL] [Abstract][Full Text] [Related]
7. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization.
Lange KH; Hougen HP; Høiby N; Fomsgaard A; Rygaard J; Johansen HK
APMIS; 1995 May; 103(5):367-74. PubMed ID: 7654361
[TBL] [Abstract][Full Text] [Related]
8. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
[TBL] [Abstract][Full Text] [Related]
9. Preservation of pulmonary function by an outer membrane protein F vaccine. A study in rats with chronic pulmonary infection caused by Pseudomonas aeruginosa.
Fox CW; Campbell GD; Anderson WM; Zavecz JH; Gilleland LB; Gilleland HE
Chest; 1994 May; 105(5):1545-50. PubMed ID: 8181349
[TBL] [Abstract][Full Text] [Related]
10. Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats.
Johansen HK; Espersen F; Pedersen SS; Hougen HP; Rygaard J; Høiby N
APMIS; 1993 Mar; 101(3):207-25. PubMed ID: 8507458
[TBL] [Abstract][Full Text] [Related]
11. Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats.
Klinger JD; Cash HA; Wood RE; Miler JJ
Infect Immun; 1983 Mar; 39(3):1377-84. PubMed ID: 6404823
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.
Theilacker C; Coleman FT; Mueschenborn S; Llosa N; Grout M; Pier GB
Infect Immun; 2003 Jul; 71(7):3875-84. PubMed ID: 12819072
[TBL] [Abstract][Full Text] [Related]
13. Experimental immunization with Pseudomonas aeruginosa alginate induces IgA and IgG antibody responses.
Johansen HK; Høiby N; Pedersen SS
APMIS; 1991 Dec; 99(12):1061-8. PubMed ID: 1772641
[TBL] [Abstract][Full Text] [Related]
14. Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia.
Sokol PA; Kooi C; Hodges RS; Cachia P; Woods DE
J Infect Dis; 2000 May; 181(5):1682-92. PubMed ID: 10823769
[TBL] [Abstract][Full Text] [Related]
15. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model.
Elhosary MA; Bahey-El-Din M; AbdelBary A; El Guink N; Aboushleib HM
Microb Pathog; 2019 Jun; 131():181-185. PubMed ID: 30978430
[TBL] [Abstract][Full Text] [Related]
16. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.
Thakur A; Kyd J; Xue M; Willcox MD; Cripps A
Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752
[TBL] [Abstract][Full Text] [Related]
17. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
Front Immunol; 2019; 10():2497. PubMed ID: 31708925
[No Abstract] [Full Text] [Related]
18. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
Gomi R; Sharma A; Wu W; Sung B; Worgall S
Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma (IFN-gamma) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats.
Johansen HK; Hougen HP; Rygaard J; Høiby N
Clin Exp Immunol; 1996 Feb; 103(2):212-8. PubMed ID: 8565302
[TBL] [Abstract][Full Text] [Related]
20. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
Hussein KE; Bahey-El-Din M; Sheweita SA
Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
